People with memory and thinking issues now have a new option, the PrecivityAD™ blood test from C2N Diagnostics. ASPR shared the story of how this test helps clinicians diagnose patients with Alzheimer’s disease in a way that is less costly and invasive than current methods. Detailed, scientifically-based messaging resulted in coverage by APbroadcast, Science magazine and others. NBC News named the test one of the medical breakthroughs of the year. As experts noted, “the pace of progress is moving even faster than anticipated.”